Zhitong financial APP, * ST eye medicine (600671.SH) disclosed the 2023 half-year report, the company achieved revenue of 50.95 million yuan, down 1.76% from the same period last year; return to the mother of net profit loss of 23.42 million yuan; deducting non-net profit loss of 21.1 million yuan; basic earnings per share-0.1923 yuan.
*ST目药(600671.SH)发布半年度业绩，净亏损2342万元
*ST Eye Drug (600671.SH) released semi-annual results, with a net loss of 23.42 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.